Modulation of estrogen receptor activity by selective coregulators

Paolo G.V. Martini, Benita S Katzenellenbogen

Research output: Contribution to journalArticle

Abstract

The estrogen receptor (ER), a member of the nuclear hormone receptor superfamily, is a hormone-regulated transcription factor that mediates the effects of estrogens and antiestrogens in breast cancer and other estrogen target cells. Because of the role of estrogens in promoting the growth and progression of breast cancer, there is great interest in exploring ways to functionally inactivate the ER, thereby suppressing ER-mediated gene expression and cell proliferation. These approaches have involved the use of antiestrogens such as tamoxifen, dominant negative ERs and, more recently, the use of corepressors. Through the use of two-hybrid screening, we have recently identified a selective repressor of estrogen receptor activity (REA). This protein is recruited to the hormone-occupied ER and selectively represses its transcriptional activity but not the other steroid and non-steroid nuclear receptors. REA also interacts with a protein, prothymosin-α (PTα), that selectively enhances ER transcriptional activity by recruiting the repressive REA protein away from ER. Analysis of the mechanisms underlying the activities of these two proteins highlights a new role for REA and PTα as activity-modulating proteins that confer receptor specificity.

Original languageEnglish (US)
Pages (from-to)117-122
Number of pages6
JournalJournal of Steroid Biochemistry and Molecular Biology
Volume85
Issue number2-5
DOIs
StatePublished - Jun 2003

Fingerprint

Estrogen Receptors
Modulation
Estrogens
Estrogen Receptor Modulators
Cytoplasmic and Nuclear Receptors
Proteins
Hormones
Breast Neoplasms
Co-Repressor Proteins
Tamoxifen
Cell proliferation
Gene expression
Transcription Factors
Steroids
Cell Proliferation
Screening
Gene Expression
Growth

Keywords

  • Coregulators
  • Estrogen receptor
  • Prothymosin-α
  • REA

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Endocrinology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Modulation of estrogen receptor activity by selective coregulators. / Martini, Paolo G.V.; Katzenellenbogen, Benita S.

In: Journal of Steroid Biochemistry and Molecular Biology, Vol. 85, No. 2-5, 06.2003, p. 117-122.

Research output: Contribution to journalArticle

@article{a74eea6d56404a6fb7b4b3bbb8d26e32,
title = "Modulation of estrogen receptor activity by selective coregulators",
abstract = "The estrogen receptor (ER), a member of the nuclear hormone receptor superfamily, is a hormone-regulated transcription factor that mediates the effects of estrogens and antiestrogens in breast cancer and other estrogen target cells. Because of the role of estrogens in promoting the growth and progression of breast cancer, there is great interest in exploring ways to functionally inactivate the ER, thereby suppressing ER-mediated gene expression and cell proliferation. These approaches have involved the use of antiestrogens such as tamoxifen, dominant negative ERs and, more recently, the use of corepressors. Through the use of two-hybrid screening, we have recently identified a selective repressor of estrogen receptor activity (REA). This protein is recruited to the hormone-occupied ER and selectively represses its transcriptional activity but not the other steroid and non-steroid nuclear receptors. REA also interacts with a protein, prothymosin-α (PTα), that selectively enhances ER transcriptional activity by recruiting the repressive REA protein away from ER. Analysis of the mechanisms underlying the activities of these two proteins highlights a new role for REA and PTα as activity-modulating proteins that confer receptor specificity.",
keywords = "Coregulators, Estrogen receptor, Prothymosin-α, REA",
author = "Martini, {Paolo G.V.} and Katzenellenbogen, {Benita S}",
year = "2003",
month = "6",
doi = "10.1016/S0960-0760(03)00207-3",
language = "English (US)",
volume = "85",
pages = "117--122",
journal = "Journal of Steroid Biochemistry and Molecular Biology",
issn = "0960-0760",
publisher = "Elsevier Limited",
number = "2-5",

}

TY - JOUR

T1 - Modulation of estrogen receptor activity by selective coregulators

AU - Martini, Paolo G.V.

AU - Katzenellenbogen, Benita S

PY - 2003/6

Y1 - 2003/6

N2 - The estrogen receptor (ER), a member of the nuclear hormone receptor superfamily, is a hormone-regulated transcription factor that mediates the effects of estrogens and antiestrogens in breast cancer and other estrogen target cells. Because of the role of estrogens in promoting the growth and progression of breast cancer, there is great interest in exploring ways to functionally inactivate the ER, thereby suppressing ER-mediated gene expression and cell proliferation. These approaches have involved the use of antiestrogens such as tamoxifen, dominant negative ERs and, more recently, the use of corepressors. Through the use of two-hybrid screening, we have recently identified a selective repressor of estrogen receptor activity (REA). This protein is recruited to the hormone-occupied ER and selectively represses its transcriptional activity but not the other steroid and non-steroid nuclear receptors. REA also interacts with a protein, prothymosin-α (PTα), that selectively enhances ER transcriptional activity by recruiting the repressive REA protein away from ER. Analysis of the mechanisms underlying the activities of these two proteins highlights a new role for REA and PTα as activity-modulating proteins that confer receptor specificity.

AB - The estrogen receptor (ER), a member of the nuclear hormone receptor superfamily, is a hormone-regulated transcription factor that mediates the effects of estrogens and antiestrogens in breast cancer and other estrogen target cells. Because of the role of estrogens in promoting the growth and progression of breast cancer, there is great interest in exploring ways to functionally inactivate the ER, thereby suppressing ER-mediated gene expression and cell proliferation. These approaches have involved the use of antiestrogens such as tamoxifen, dominant negative ERs and, more recently, the use of corepressors. Through the use of two-hybrid screening, we have recently identified a selective repressor of estrogen receptor activity (REA). This protein is recruited to the hormone-occupied ER and selectively represses its transcriptional activity but not the other steroid and non-steroid nuclear receptors. REA also interacts with a protein, prothymosin-α (PTα), that selectively enhances ER transcriptional activity by recruiting the repressive REA protein away from ER. Analysis of the mechanisms underlying the activities of these two proteins highlights a new role for REA and PTα as activity-modulating proteins that confer receptor specificity.

KW - Coregulators

KW - Estrogen receptor

KW - Prothymosin-α

KW - REA

UR - http://www.scopus.com/inward/record.url?scp=0042388778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042388778&partnerID=8YFLogxK

U2 - 10.1016/S0960-0760(03)00207-3

DO - 10.1016/S0960-0760(03)00207-3

M3 - Article

C2 - 12943695

AN - SCOPUS:0042388778

VL - 85

SP - 117

EP - 122

JO - Journal of Steroid Biochemistry and Molecular Biology

JF - Journal of Steroid Biochemistry and Molecular Biology

SN - 0960-0760

IS - 2-5

ER -